G. Claus

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan Paul Piccini, Susanna R. Stevens, Manesh R. Patel et autres

BACKGROUND: Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. METHODS AND RESULTS: In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for …

us, de, au, gb (code pays fourni par la source)

Atrial Myxoma Syndrome Mimicking Ehrmann-Sneddon Syndrome

Elke Weißhaar, G. Claus, Andrea Friedl, Harald P. M. Gollnick

Livedo racemosa with cerebrovascular lesions has been described as Ehrmann-Sneddon syndrome. The etiopathogenetic factors provoking the vascular lesions, however, are of high diversity reaching from mechanical to autoimmune causes. We present a male patient with typical livedo racemosa, muscle pain and feeling …

de, at (code pays fourni par la source)

Acknowledgment to Referees for Dermatology 1997

Lars Einar French, Markus Stücker, Peter Hügler, G. von Kohyletzki et autres

P002 Myxoma of the heart — Presenting as livedo vasculitis (Ehrmann-Sneddon-Syndrome)

Elke Weißhaar, G. Claus, Andrea Friedl, Harald P. M. Gollnick

[Undesirable side effects in thrombolytic therapy].

G. Claus, Dietrich C. Gulba

Even with the new fibrin-specific plasminogen activators thrombolytic therapy remains burdened with numerous side effects, some of them being severe or even life threatening, therapists being horrified if in rare cases the patient dies from severe haemorrhage subsequent to thrombolysis. The incidence …

de (code pays fourni par la source)

[Thrombolytic therapy of myocardial infarct. Status after GISSI-2 and ISIS-3].

Dietrich C. Gulba, G. Claus

de (code pays fourni par la source)

188 Fibrinolytic therapy of acute myocardial infarction: The systemic effects of RT-PA as compared to urukinase

Alexandra Eilers, G. Claus, Rainer Muche, Ullrich Tebbe et autres

360 Procoagulant activity (PCA) in isolated human monocytes induced by modified low density lipoproteins (LDL)

G. Claus, Peter Schuff‐Werner, Alexander Eilers, V. Amrstrong et autres

ChemInform Abstract: Platelet Aggregation Inhibiting and Anticoagulant Effects of Oligoamines. Part 3. 1,3‐Phenylenebis(alkanamines).

Klaus Rehse, U. LUEKENS, Susanne Leißring, G. Claus

Kontrollierte Studie zur Wirkungsweise und Wirkungsdauer von Molsidomin bei Patienten mit koronarer Herzkrankheit unter besonderer Berücksichtigung der Echokardiographie

G. Claus

Middle-Ear and Mastoid Inflammation in Typhus Fever.

G. Claus